LA
CRL icon

LBP AM’s Charles River Laboratories CRL Stock Holding History

LBP AM’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,411
Closed -$911K – 371
2024
Q2 		$911K Buy
4,411
+350
+9% +$79.3K 0.04% 272
2024
Q1 		$1.1M Buy
4,061
+1,929
+90% +$461K 0.04% 220
2023
Q4 		$504K Hold
2,132
– – 0.01% 377
2023
Q3 		$418K Buy
+2,132
New +$438K 0.01% 436

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

LBP AM's CRL Position: Q3 2024 in Review

LBP AM sold out of Charles River Laboratories (CRL) in Q3 2024, closing a stake of 4,411 shares — an estimated $911K sold.

LBP AM first reported a position in CRL in Q3 2023 and held it in 4 quarters. The position peaked at $1.1M in Q1 2024. 628 funds tracked by Wall St. Rank hold CRL as of Q3 2024.

  • LBP AM reported no remaining Charles River Laboratories position as of Q3 2024 after selling out during the quarter.
  • LBP AM sold 4,411 Charles River Laboratories shares in Q3 2024, an estimated $911K.
  • LBP AM first reported a position in Charles River Laboratories in Q3 2023 and held it in 4 quarters.
  • LBP AM's Charles River Laboratories position peaked at $1.1M in Q1 2024.
  • 628 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2024.

Based on LBP AM's 13F filing for Q3 2024, filed 12 Nov 2024.